Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$775.18 - $881.7 $4,651 - $5,290
6 Added 9.68%
68 $59,000
Q3 2022

Nov 01, 2022

BUY
$573.97 - $724.32 $573 - $724
1 Added 1.64%
62 $42,000
Q2 2022

Aug 10, 2022

SELL
$548.35 - $738.84 $1,096 - $1,477
-2 Reduced 3.17%
61 $36,000
Q1 2022

May 11, 2022

BUY
$595.12 - $698.43 $24,399 - $28,635
41 Added 186.36%
63 $44,000
Q2 2019

Jul 30, 2019

BUY
$299.6 - $414.82 $6,591 - $9,126
22 New
22 $7,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.